Antibiotic treatment of children with community-acquired pneumonia: Comparison of penicillin or ampicillin versus cefuroxime

Pediatric Pulmonology

Volumn 48, Issue 1, 2013, Pages 52-58

  Dinur Schejter, Yael ^a   Cohen Cymberknoh, Malena ^a   Tenenbaum, Ariel ^a   Brooks, Rebecca ^a   Averbuch, Diana ^a   Kharasch, Sigmund ^a   Kerem, Eitan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

ampicillin; cefuroxime; children; community acquired pneumonia; pediatrics; penicillin; resistance; treatment

Indexed keywords

AMPICILLIN; CEFUROXIME; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEVER; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITALIZED CHILD; HOSPITALIZED INFANT; HUMAN; INFANT; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; OXYGEN THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

EID: 84872859405     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22534     Document Type: Article

References (39)

1. Hale KA, Isaacs D,. Antibiotics in childhood pneumonia. Paediatr Respir Rev 2006; 7: 145-151.
2. Stralin K,. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrobial Agents 2008; 31: 3-11.
3. Kabra SK, Lodha R, Pandey RM,. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 2006; 3: 1-98.
4. Zar HJ, Jeena P, Argent A, Gie R, Madhi SA, Members of the Working Groups of the Paediatric Assembly of the South African Thoracic Society. Diagnosis and Management of Community-Acquired Pneumonia in Childhood-South African Thoracic Society Guidelines. S Afr Med J 2005; 95: 977-989.
5. Sinaniotis CA, Sinaniotis AC,. Community-acquired pneumonia in children. Curr Opin Pulm Med 11: 218-225.
6. McIntosh K,. Community acquired pneumonia in children. N Engl J Med 2002; 346: 429-437.
7. Mufson MA, Chan G, Stanek RJ,. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started. Am J Med Sci 2007; 333: 161-167.
8. Cardoso MRA, Nascimento-Carvalho CM, Ferrero F, Berezin EN, Ruvinsky R, Camargos PAM, Sant'Anna CC, Brandileone MCC, March MFP, Feris-Iglesias J, et al. Penicillin resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 2007. DOI: 10.11136/adc.2006.111625.
9. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, Canadian Community-Acquired Pneumonia Working Group. Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383-421.
10. Rahav G, Toledano Y, Engelhard D, Simhon A, Moses AE, Sacks T, Shapiro M,. Invasive pneumococcal infections: A comparison between adults and children. Rev Mol Med 1997; 76: 295-303.
11. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90: 223-229.
12. Tan TQ, Mason EO, Jr, Barson WJ, Wald ER, Schutze GE, Bradley JS, Arditi M, Givner LB, Yogev R, Kim KS, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998; 102: 1369-1375.
13. Juven T, Mertsola J, Waris M, Leinonen M, Ruuskanen O,. Clinical response to antibiotic therapy for community-acquired pneumonia. Eur J Pediatr 2004; 163: 140-144.
14. Tan TQ, Mason EO, Jr, Wald ER, Barson WJ, Schutze GE, Bradley JS, Givner LB, Yogev R, Kim KS, Kaplan SL,. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002; 110: 1-6.
15. Peterson LR,. Penicillins for treatment of pneumococcal pneumonia: Does in vitro resistance really matter ? Clin Infect Dis 2006; 42: 224-233.
16. Falagas ME, Siempos II, Bliziotis IA, Panos GZ,. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: A systematic review. Mayo Clin Proc 2006; 81: 1567-1574.
17. Wexler IS, Knoll S, Picard E, Villa Y, Shoseyov D, Engelhard D, Kerem E,. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol 2006; 41: 726-734.
18. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR,. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-1465.
19. Nathwani D, Williams F, Winter J, Winter J, Ogston S, Davey P,. Use of indicators to evaluate the quality of community-acquired pneumonia management. Clin Infect Dis 2002; 34: 318-323.
20. Shek FW, Stacey BS, Rendell J, Hellier MD, Hanson PSV,. The rise of Clostridium difficile: The effect of length of stay, patient age and antibiotic use. J Hosp Infect 2000; 45: 235-237.
21. Spencer RC,. Clinical impact and associated costs of Clostridium difficile associated disease. J Anti microb Chemother 1998; 41: 5-12.
22. Thomas C, Stevenson M, Riley TV,. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: A systematic review. J Antimicrob Chemother 2003; 51: 1339-1350.
23. Yu VL, Chiou CCC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, et al. An International Prospective Study of Pneumococcal Bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-237.
24. Vuori-Holopainen E, Peltola H, Kallio MJ,. Narrow-versus broad-spectrum parenteral antimicrobials against common infections of childhood: A prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr 2000; 159: 878-884.
25. Aspa J, Rajas O, Rodriguez de Castro F, Blanquer J, Zalacain R, Fenoll A, de Celis R, Vargas A, Salvanes FR, Espana PP, et al. Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors. Clin Infect Dis 2004; 38: 787-798.
26. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Mushe DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG, Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160: 1399-1408.
27. Kaplan SL, Mason EO, Jr, Barson WJ, Tan TQ, Schutze GE, Bradley JS, Givner LB, Kim KS, Yogev R, Wald ER,. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J 2001; 20: 392-396.
28. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Jr, Musher DM, Niederman MS, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007; 44: S27-S72.
29. British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults 2004 update. http://wwwbrit-thoracicorguk/c2/ uploads/MACAPrevisedApr04pdf, 2004.
30. Barlow G, Nathwani D, Davey P,. The effect of implementing the British Thoracic Society community-acquired pneumonia guidelines on antibiotic prescribing and costs in a UK teaching hospital. Clin Microbiol Infect 2006; 12: 498-500.
31. Collini P, Beadsworth M, Anson J, Neal T, Burnham P, Deegan P, Beeching N, Miller A,. Community-acquired pneumonia: Doctors do not follow national guidelines. Postgrad Med J 2007; 83: 552-555.
32. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C,. Estimates of worldwide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002; 2: 25-32.
33. World Health Organization. The World Health Report 2005. Make every mother and child count. Geneva: World Health Organization; 2005. http://www.who.int/whr2005-en.pdf
34. World Health Organization (WHO). Technical bases for the WHO recommendations on management of pneumonia in children at first level health facilities. Geneva: WHO; 1991, WHO/ARI/91.20.
35. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113: 701-707.
36. World Health Organization (WHO). ARI in children: Case management in small hospitals in developing countries. A manual for doctors other senior health workers. Programme for the Control of ARI. Geneva: WHO; 1990.
37. Sazawal S, Black RE,. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: A meta-analysis of community-based trials. Lancet Infect Dis 2003; 3: 547-556.
38. Kwang SK,. Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010; 10: 32-42.
39. Hersh AL, Shapiro DJ, Pavia AT, et al. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 2011; 128: 1053-1061.